SPY319.34+8.04 2.58%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Arcutis Biotherapeutics Q1 EPS $(1.150) Misses $(0.920) Estimate

Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(1.150) per share which missed the analyst consensus estimate of $(0.920) by 25 percent.

Benzinga · 05/12/2020 20:09

Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(1.150) per share which missed the analyst consensus estimate of $(0.920) by 25 percent.